Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 92
Filter
1.
Osteoporos Int ; 25(7): 1969-73, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24718377

ABSTRACT

UNLABELLED: The increased risk for fractures in type 2 diabetes mellitus (T2DM) despite higher average bone density is unexplained. This study assessed trabecular bone quality in T2DM using the trabecular bone score (TBS). The salient findings are that TBS is decreased in T2DM and low TBS associates with worse glycemic control. INTRODUCTION: Type 2 diabetes mellitus is a risk factor for osteoporotic fractures despite high average bone mineral density (BMD). The aim of this study was to compare BMD with a noninvasive assessment of trabecular microarchitecture, TBS, in women with T2DM. METHODS: In a cross-sectional study, trabecular microarchitecture was examined in 57 women with T2DM and 43 women without diabetes, ages 30 to 90 years. Lumbar spine BMD was measured by dual-emission x-ray absorptiometry (DXA), and TBS was calculated by examining pixel variations within the DXA images utilizing TBS iNsight software. RESULTS: Mean TBS was lower in T2DM (1.228 ± 0.140 vs. 1.298 ± 0.132, p = 0.013), irrespective of age. Mean BMD was higher in T2DM (1.150 ± 0.172 vs. 1.051 ± 0.125, p = 0.001). Within the T2DM group, TBS was higher (1.254 ± 0.148) in subjects with good glycemic control (A1c ≤ 7.5 %) compared to those (1.166 ± 0.094; p = 0.01) with poor glycemic control (A1c > 7.5 %). CONCLUSION: In T2DM, TBS is lower and associated with poor glycemic control. Abnormal trabecular microarchitecture may help explain the paradox of increased fractures at a higher BMD in T2DM. Further studies are needed to better understand the relationship between glycemic control and trabecular bone quality.


Subject(s)
Diabetes Mellitus, Type 2/complications , Osteoporotic Fractures/etiology , Absorptiometry, Photon/methods , Aged , Body Mass Index , Bone Density/physiology , Cross-Sectional Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/physiopathology , Female , Glycated Hemoglobin/metabolism , Humans , Hypoglycemic Agents/therapeutic use , Lumbar Vertebrae/physiopathology , Middle Aged , Osteoporotic Fractures/physiopathology , Retrospective Studies
2.
Bone ; 48(2): 281-5, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20858558

ABSTRACT

CONTEXT: Paget's disease of bone (PDB) is a focal disorder of bone metabolism with overgrowth of affected bone resulting in the skeletal complications of this disease. OBJECTIVE: This study examines what patients know about the skeletal distribution of their PDB, and correlates this with their reports of complications and quality of life. DESIGN: The New England Registry for PDB (NRPD) is a voluntary registry with a questionnaire linked to a radiographic database. Data were collected by mail beginning in 2001. SETTING: Ambulatory population. PATIENTS: Any patient with PDB living in New England was eligible to enroll; 285 elected to participate, mean age 73.2 years. MAIN OUTCOME MEASURES: Patients were asked what bones were affected by PDB, and whether they suffered complications from PDB. Radiographic studies were sought to corroborate their responses. An SF-12 was administered. RESULTS: Compared to the general population, they reported substantially lower levels of physical health (Physical Component Score (PCS) mean=40), and slightly better mental health (Mental Component Score (MCS) mean=52). There were more instances of agreement on disease presence and fewer instances on disagreement (p=0.001). Radiographic studies supported the presence of a complication from PDB when deformity, fracture and joint replacement had occurred, but were less correlative when headache or hearing loss was reported. CONCLUSIONS: Most patients with PDB are aware of the skeletal distribution of their disease; there is a reasonable correlate between complications ascribed to PDB and the presence of PDB on the radiograph except when headache or hearing loss is reported.


Subject(s)
Osteitis Deformans/pathology , Adult , Aged , Aged, 80 and over , Aging , Humans , Middle Aged , Osteitis Deformans/complications , Osteitis Deformans/physiopathology , Quality of Life , Surveys and Questionnaires
3.
Pac Symp Biocomput ; : 324-35, 2004.
Article in English | MEDLINE | ID: mdl-14992514

ABSTRACT

The preferential conservation of transcription factor binding sites implies that non-coding sequence data from related species will prove a powerful asset to motif discovery. We present a unified probabilistic framework for motif discovery that incorporates evolutionary information. We treat aligned DNA sequence as a mixture of evolutionary models, for motif and background, and, following the example of the MEME program, provide an algorithm to estimate the parameters by Expectation-Maximization. We examine a variety of evolutionary models and show that our approach can take advantage of phylogenic information to avoid false positives and discover motifs upstream of groups of characterized target genes. We compare our method to traditional motif finding on only conserved regions. An implementation will be made available at http://rana.lbl.gov.


Subject(s)
Computational Biology , Evolution, Molecular , Phylogeny , Algorithms , Base Sequence , DNA, Fungal/genetics , DNA-Binding Proteins/genetics , Fungal Proteins/genetics , Likelihood Functions , Models, Genetic , Models, Statistical , Saccharomyces/genetics , Software
6.
J Clin Endocrinol Metab ; 83(3): 824-9, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9506735

ABSTRACT

Most individuals with Albright's hereditary osteodystrophy (AHO) have deficient expression or function of G(s alpha), the alpha subunit of the guanine nucleotide binding protein that stimulates adenylyl cyclase, and are resistant to parathyroid hormone (PTH) and other hormones that act via stimulation of adenylyl cyclase. To determine the incidence and etiology of ovarian dysfunction in women with AHO, we examined the reproductive history and hypothalamic-pituitary-ovarian axis in 17 affected women aged 17-43 yr. All patients had typical PTH resistance and an approximately 50% reduction in erythrocyte G(s alpha) activity, (0.43 +/- 0.03 vs. 0.92 +/- 0.08 for normal control subjects, P < 0.001). Fourteen of the 17 patients (76%) were oligomenorrheic or amenorrheic, more than half had delayed or incomplete sexual development, and only two had a history of earlier pregnancy. Most women were mildly hypoestrogenic, with normal to slightly elevated serum gonadotropin levels. Computer analysis of 24 hour LH measurement showed that the frequency of LH peaks/24 h in AHO women varied widely, but as a group they were not statistically different from a group of normal women studied in the early follicular phase. Administration of 100 microg synthetic GnRH produced normal FSH and LH responses. We conclude that reproductive dysfunction is common in women with AHO and probably represents partial resistance to gonadotropins.


Subject(s)
Fibrous Dysplasia, Polyostotic/genetics , Fibrous Dysplasia, Polyostotic/physiopathology , Reproduction/physiology , Adolescent , Adult , Female , Fibrous Dysplasia, Polyostotic/complications , Follicle Stimulating Hormone/blood , GTP-Binding Proteins/blood , GTP-Binding Proteins/genetics , Gonadotropin-Releasing Hormone , Hormones/blood , Humans , Luteinizing Hormone/blood , Medical Records , Ovary/pathology , Pseudohypoparathyroidism/etiology , Pseudohypoparathyroidism/physiopathology , Pulsatile Flow , RNA, Messenger/metabolism
7.
Hum Mol Genet ; 6(11): 1865-71, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9302264

ABSTRACT

Congenital nephrogenic diabetes insipidus (NDI) is a rare disease caused most often by mutations in the vasopressin V2 receptor (AVPR2). We studied a family which included a female patient with NDI with symptoms dating from infancy. The patient responded to large doses of desmopressin (dDAVP) which decreased urine volume from 10 to 4 I/day. Neither the parents nor the three sisters were polyuric. The patient was found to be a compound heterozygote for two novel recessive point mutations in the aquaporin-2 (AQP2) gene: L22V in exon 1 and C181W in exon 3. Residue Cys181 in AQP2 is the site for inhibition of water permeation by mercurial compounds and is located near to the NPA motif conserved in all aquaporins. Osmotic water permeability (Pf) in Xenopus oocytes injected with cRNA encoding C181W-AQP2 was not increased over water control, while expression of L22V cRNA increased the Pf to approximately 60% of that for wild-type AQP2. Co-injection of the mutant cRNAs with the wild-type cRNA did not affect the function of the wild-type AQP2. Immunolocalization of AQP2-transfected CHO cells showed that the C181W mutant had an endoplasmic reticulum-like intracellular distribution, whereas L22V and wild-type AQP2 showed endosome and plasma membrane staining. Water permeability assays showed a high Pf in cells expressing wild-type and L22V AQP2. This study indicates that AQP2 mutations can confer partially responsive NDI.


Subject(s)
Aquaporins , Deamino Arginine Vasopressin/therapeutic use , Diabetes Insipidus, Nephrogenic/genetics , Hypoglycemic Agents/therapeutic use , Ion Channels/genetics , Amino Acid Sequence , Animals , Aquaporin 2 , Aquaporin 6 , CHO Cells , Cricetinae , DNA Mutational Analysis , Diabetes Insipidus, Nephrogenic/drug therapy , Female , Humans , Male , Molecular Sequence Data , Mutation , Pedigree
8.
J Clin Endocrinol Metab ; 80(4): 1184-6, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7714087

ABSTRACT

Almost all cases of congenital nephrogenic diabetes insipidus (NDI) are transmitted in an X-linked recessive manner by an asymptomatic carrier female to her affected son. Severe symptomatic NDI has not previously been reported in a female with X-linked recessive NDI. Each of the three members of this family has an abnormal V2 receptor gene, which results in truncation of the V2 receptor beginning at arginine-337. This prematurely terminates the receptor at the carboxy-terminal tail and very likely disrupts receptor function. The son has an abnormal V2 receptor gene on his X-chromosome, whereas the mother and daughter have one normal and one abnormal gene for the V2 receptor. The infusion of desmopressin into the mother and son reveals a total lack of antidiuretic response, whereas the daughter increases urinary osmolality normally. The plasma factor VIII concentration after the infusion of desmopressin in the son does not rise, whereas the mother and daughter have half of the normal factor VIII response, similar to asymptomatic female carriers of NDI. These responses to desmopressin in daughter and son are those of a typical carrier female and male affected with NDI. In contrast, the mother acts as an NDI patient when the urine concentration is measured, but acts as a carrier in terms of the factor VIII response to desmopressin. We postulate that the renal tubular cells of the mother demonstrate extreme lyonization of X-chromosome inactivation, whereas in the tissue that subserves the hematological response to desmopressin, X-chromosome inactivation followed a more typically random distribution.


Subject(s)
Diabetes Insipidus/genetics , Genetic Linkage , Receptors, Vasopressin/genetics , Vasopressins/physiology , X Chromosome , Adult , Child , Deamino Arginine Vasopressin/pharmacology , Diabetes Insipidus/physiopathology , Diuresis/drug effects , Drug Resistance , Factor VIII/analysis , Female , Genes, Recessive , Humans , Kidney Concentrating Ability , Male , Osmolar Concentration
9.
J Am Soc Nephrol ; 5(7): 1451-61, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7703383

ABSTRACT

X-linked recessive nephrolithiasis (XRN) was described in a large kindred in which nephrolithiasis; proximal tubular dysfunction, proteinuria, nephrocalcinosis, and renal failure occur only in males. Carrier females are asymptomatic, but formal studies of them have not been done. The gene for XRN has been mapped to the pericentromeric region of the X chromosome, close to the loci for several eye disease genes. We studied six affected males, 13 carrier females, and 25 normal members of this family including 7 females whose genetic haplotype predicted them to be carriers. Studies were done in the Clinical Research Unit on a diet containing 400 mg of calcium and 2 g of sodium, and by an additional outpatient urine collection was obtained on a 1-g calcium intake. Hypercalciuria occurred in five of six affected males, 4 of 12 carrier females, and three of seven predicted carriers. Significant proteinuria was present in all affected males and in no other subjects. Low-molecular-weight proteinuria was present in all affected males: the excretion of alpha 1-microglobulin exceeded normal by 3- to 14-fold, of beta 2-microglobulin exceeded normal by 100- to 400-fold, and of retinol-binding protein exceeded normal by 1,000- to 3,000-fold. The excretion of these proteins was less strikingly elevated in carrier females, but the excretion of alpha 1-microglobulin was abnormal in 9 of 15 carriers, beta 2-microglobulin was abnormal in 12 of 15, and retinolbinding protein in was abnormal 12 of 13, and this pattern was similar in predicted carriers. The urinary concentrating ability was abnormal in four affected males with renal insufficiency but normal in all other subjects. Urinary wasting of potassium, phosphorous, and glucose occurred infrequently, and no subject was hypouricemic. Formal ophthalmologic studies were normal in five affected males. Thus, the most consistent urinary abnormalities in XRN are hypercalciuria and low-molecular-weight proteinuria, the latter of which appears to be a marker for the carrier state.


Subject(s)
Carrier State , Genes, Recessive , Genetic Linkage , Kidney Calculi/genetics , X Chromosome , Adolescent , Adult , Aged , Calcium/urine , Child , Child, Preschool , Creatinine/metabolism , Eye/physiopathology , Female , Humans , Kidney Calculi/physiopathology , Kidney Calculi/urine , Kidney Tubules/physiopathology , Male , Middle Aged , Phenotype , Proteinuria/urine
10.
Am J Kidney Dis ; 24(4): 575-7, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7942812

ABSTRACT

Propylthiouracil therapy is associated with a variety of adverse reactions. Renal involvement, although rare, has occurred, but neither acute interstitial nephritis nor severe acute renal failure has been reported previously. We report a case of fulminant acute interstitial nephritis with renal failure following treatment with propylthiouracil.


Subject(s)
Acute Kidney Injury/chemically induced , Nephritis, Interstitial/chemically induced , Propylthiouracil/adverse effects , Acute Disease , Adult , Humans , Male
13.
Am J Physiol ; 265(6 Pt 2): R1247-52, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8285264

ABSTRACT

The secretion of arginine vasopressin (AVP) from the posterior pituitary is primarily and finely regulated by the osmolality of plasma. Even though a number of factors alter osmolality-induced release of AVP, there are no published data in humans that have addressed the role of chronic overhydration on this phenomenon. To address this problem we have identified eight patients with primary polydipsia using criteria not involving measurement of AVP, and have subjected them to standardized infusions of hypertonic saline. These patients had less AVP in both plasma and urine in relation to plasma osmolality than was found in normal subjects. In addition, their rate of rise of plasma and urine AVP was less than in normal subjects. Their osmotic threshold for AVP release may have been higher than normal. These data demonstrate that chronic overhydration in humans downregulates the release of AVP in response to hypertonicity. This phenomenon may explain the impairment of urine concentration in patients with primary polydipsia and emphasizes the basis of the difficulty that may occur clinically in differentiating between patients with primary polydipsia and partial central diabetes insipidus.


Subject(s)
Arginine Vasopressin/blood , Saline Solution, Hypertonic/pharmacology , Thirst/physiology , Adult , Arginine Vasopressin/urine , Female , Humans , Male , Osmolar Concentration , Reference Values , Regression Analysis
14.
Ann N Y Acad Sci ; 689: 233-49, 1993 Jul 22.
Article in English | MEDLINE | ID: mdl-8373015

ABSTRACT

The DI +/+ Severe hereditary nephrogenic diabetes insipidus mouse is resistant to the antidiuretic action of vasopressin (VP) because of failure to accumulate cAMP and subsequent inability to form intramembranous particles on the apical (luminal) surface of kidney cells that normally respond to VP. The defect is primarily, if not exclusively, due to excessive activity of specific cAMP-phosphodiesterases. The abnormality can be overcome in vitro and in vivo by the phosphodiesterase inhibitor, rolipram. Most cases of hereditary NDI in man have sex-linked recessive inheritance, which appears to be due to an abnormality of the V2 receptor. The chromosomal locus of the defect is Xq28. Sporadic cases of congenital NDI have been described in females who appear to have a defect beyond the V2 receptor and the guanine nucleotide-binding stimulatory protein. There is no information on the biochemical defect in very rare cases with other types of inheritance patterns. No abnormalities of V1a and V1b receptor function have been found in patients with NDI. Mice and patients with NDI have evidence of increased AVP synthesis. AVP release in relation to plasma osmolality is increased in patients during infusion of hypertonic saline. This is the opposite of what has been described in patients with primary polydipsia (dipsogenic diabetes insipidus) who are chronically overhydrated. Together, these studies indicate that chronic dehydration and overhydration can cause up- and downregulation of the osmotic release of AVP.


Subject(s)
Arginine Vasopressin/physiology , Diabetes Insipidus/genetics , Animals , Diabetes Insipidus/congenital , Diabetes Insipidus/veterinary , Drug Resistance/genetics , Humans , Kidney Concentrating Ability , Mice , Pituitary Gland, Posterior/physiopathology , Rodent Diseases/physiopathology
15.
AJNR Am J Neuroradiol ; 13(5): 1273-7, 1992.
Article in English | MEDLINE | ID: mdl-1414815

ABSTRACT

PURPOSE: To investigate the value of MR in differentiating patients with primary polydipsia, who have an intact neurohypophyseal system, from those with central diabetes insipidus, who have impaired synthesis and/or release of vasopressin. METHODS: Eighteen patients with clinically significant hypotonic polyuria were diagnosed endocrinologically as having primary polydipsia or diabetes insipidus (central or nephrogenic). These patients, and 92 patients without sellar disease, were then imaged with 1.5-T, T1-weighted, thin sagittal sections without gadolinium contrast. RESULTS: Normal hyperintense signal of the neurohypophysis was present in 90 of 92 patients without sellar disease. The signal was also present in all six patients with primary polydipsia. In contrast, the hyperintense signal was absent in all eight patients with central diabetes insipidus. Three of the four patients with nephrogenic diabetes insipidus also had an absent hyperintense signal. CONCLUSION: T1-weighted MR may prove important in differentiating patients with central diabetes insipidus from those with primary polydipsia.


Subject(s)
Diabetes Insipidus/diagnosis , Magnetic Resonance Imaging , Polyuria/diagnosis , Thirst , Adult , Child, Preschool , Diagnosis, Differential , Female , Humans , Male
16.
Am J Physiol ; 263(2 Pt 2): R273-8, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1387294

ABSTRACT

Atrial natriuretic peptide (ANP) antagonizes the release and action of arginine vasopressin (AVP) both in vivo and in vitro. We have reported that ANP increases the urinary and metabolic clearances of AVP in normal subjects (A. M. Moses et al. J. Clin. Endocrinol. Metab. 70: 222-229, 1990). To clarify this effect, we perfused isolated rat kidneys in vitro and measured the clearances of AVP for 30 min after the addition of rat ANP [rANP-(1-28), 10(-7) M]. In the perfused kidney, rANP increased the urinary clearance of AVP (UCAVP) from 321 +/- 19 to 417 +/- 20 microliters/min (P less than 0.01) and increased the glomerular filtration rate (GFR) from 558 +/- 28 to 696 +/- 28 microliters/min (P less than 0.01). Fractional excretion of AVP was unchanged. Rates of AVP reabsorption were directly related to filtered AVP, and this relationship was not altered by ANP. ANP did not affect the total organ clearance or the renal metabolic clearance of AVP. The increase in GFR was associated with increases in renal vascular resistance (P less than 0.05), filtration fraction (P less than 0.01), and sodium excretion (P less than 0.001). UCAVP also increased when GFR was raised without ANP by perfusing at higher pressures. The rat ANP clearance receptor agonist [cANP- (4-23), 10(-7) M] did not change GFR or UCAVP. ANP increases UCAVP in the isolated perfused rat kidney. This appears to be a hemodynamic effect of ANP, acting through its biological receptor and not the clearance receptor.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Arginine Vasopressin/metabolism , Atrial Natriuretic Factor/pharmacology , Kidney/metabolism , Animals , Arginine Vasopressin/urine , Glomerular Filtration Rate/drug effects , In Vitro Techniques , Male , Perfusion , Pressure , Rats , Rats, Inbred Strains , Renal Circulation/drug effects , Vascular Resistance/drug effects
18.
Endocrinol Metab Clin North Am ; 20(3): 489-506, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1935917

ABSTRACT

A great deal of information has been accumulated on the synthesis and release of AVP, oxytocin, and their associated neurophysins under normal circumstances. In 1957, Schwartz and Bartter first described SIAD in patients with lung cancer and postulated that the clinical findings were the results of excessive vasopressin secretion. Tumors have been known since 1964 to produce vasopressin, and small cell (oat cell) carcinoma of the lung is by far the most frequent malignant cause of SIAD. The biosynthetic pathway for the synthesis of AVP and its associated neurophysin (and to a lesser extent, oxytocin and its neurophysin) is well described and is similar if not identical to the synthesis of these peptides in the hypothalamus. However, there is little reliable information on the control of peptide synthesis and release by these tumors. The clinical picture of SIAD is well described and occurs in 20% to 40% of patients with SCCL, although up to 88% of patients with extensive SCCL have elevated circulating levels of one or more neurohypophyseal peptides. This information has led to considerable interest in the use of these peptides as tumor markers for the diagnosis, evaluation, and assessment of therapy in these patients. With the recognition of the high incidence of secretion of neurohypophyseal peptides by SCCL, studies have been initiated to determine the value of radioactive vasopressin neurophysin antibodies in localizing tumors that synthesize these peptides. The studies provide potentially useful information in diagnosing and following patients with SCCL and also offer some promise that radiolabeled antineurophysins could eventually be used to treat these patients.


Subject(s)
Hormones, Ectopic/metabolism , Hypothalamic Hormones/metabolism , Paraneoplastic Endocrine Syndromes/physiopathology , Biomarkers, Tumor , Fluid Therapy , Hormones, Ectopic/biosynthesis , Humans , Hypothalamic Hormones/biosynthesis , Hypothalamus/metabolism , Inappropriate ADH Syndrome/physiopathology , Inappropriate ADH Syndrome/therapy , Neurophysins/metabolism , Oxytocin/metabolism , Paraneoplastic Endocrine Syndromes/metabolism , Sodium/urine , Vasopressins/metabolism
19.
South Med J ; 83(12): 1475-7, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2123565

ABSTRACT

Individuals receiving lithium carbonate commonly have nephrogenic diabetes insipidus. There is no effective and practical treatment for this condition. We have found that large doses of desmopressin (DDAVP) may provide effective therapy without adverse effects. A recent report showed that indomethacin improved nephrogenic diabetes insipidus that had persisted after the lithium therapy was discontinued. We have provided additional evidence that indomethacin may be effective, even when treatment with lithium is continued. We also have shown that indomethacin together with desmopressin can markedly decrease polyuria, though indomethacin must be used with care because it may impair renal function.


Subject(s)
Antiviral Agents/adverse effects , Deamino Arginine Vasopressin/therapeutic use , Diabetes Insipidus/chemically induced , Indomethacin/therapeutic use , Kidney Diseases/drug therapy , Lithium/adverse effects , Adult , Deamino Arginine Vasopressin/administration & dosage , Diabetes Insipidus/blood , Diabetes Insipidus/urine , Drug Evaluation , Drug Synergism , Drug Therapy, Combination , Female , Humans , Indomethacin/administration & dosage , Injections, Subcutaneous , Kidney Diseases/blood , Kidney Diseases/chemically induced , Kidney Diseases/urine , Lithium Carbonate , Osmolar Concentration
20.
J Clin Invest ; 85(3): 921-8, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2155931

ABSTRACT

Studies in vitro have shown that L-histidine increases the hydroosmotic response to vasopressin. We examined whether this phenomenon occurs also in vivo. Homozygous Brattleboro rats (di/di) were fed a regular diet (0.5% histidine) or a diet enriched with histidine and received 1 ng of 1-deamino-8-D-arginine vasopressin (dDAVP) daily. Addition of histidine (1% by weight) increased post-dDAVP urine osmolality to a level higher than that of control (502 +/- 62 vs. 316 +/- 36 mosmol/kg, P less than 0.05). Similar results were seen with 3.0% and 5.5% dietary histidine. There were significant increases in free-water reabsorption and in the ratio of free-water reabsorption to osmolar clearance, but no difference in osmolal clearance. No significant effect was found with supplemental histidine of 0.5% or less. The cause for these findings appears not to be the metabolism of histidine, since the nonmetabolizable D-histidine had a significant, albeit smaller, effect, and the isonitrogenous addition of albumin, alanine, arginine, or glutamine was ineffective. In part, histidine may operate by increasing cAMP since the renal cAMP content in response to vasopressin is increased in histidine-fed rats (13.1 +/- 0.9 vs. 9.8 +/- 0.8 nmol/g dry weight, P less than 0.01). The role of prostaglandins appears less clear. Histidine greatly decreased urinary PGE2 during baseline (1.5 +/- 0.3 vs. 7.0 +/- 2.3 micrograms/mg creatinine, P less than 0.001), but it profoundly augmented urinary prostaglandin excretion after dDAVP stimulation (40.0 +/- 4.2 vs. 7.0 +/- 2.0 micrograms/mg creatinine, P less than 0.001).


Subject(s)
Deamino Arginine Vasopressin/pharmacology , Histidine/pharmacology , Kidney/drug effects , Animals , Creatinine/metabolism , Cyclic AMP/analysis , Dinoprostone/urine , Diuresis/drug effects , Electrolytes/urine , Female , Histidine/blood , Homozygote , Kidney/metabolism , Rats , Rats, Brattleboro
SELECTION OF CITATIONS
SEARCH DETAIL
...